CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 56 filers reported holding CARDIFF ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 18.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,227 | -6.7% | 71,386 | -1.4% | 0.00% | – |
| Q2 2023 | $106,407 | -8.4% | 72,386 | +2.8% | 0.00% | – |
| Q1 2023 | $116,198 | +19.6% | 70,423 | +1.5% | 0.00% | – |
| Q4 2022 | $97,138 | -9.2% | 69,384 | 0.0% | 0.00% | – |
| Q3 2022 | $107,000 | -27.2% | 69,384 | +4.2% | 0.00% | – |
| Q2 2022 | $147,000 | -81.3% | 66,592 | -79.0% | 0.00% | – |
| Q1 2022 | $788,000 | -61.3% | 317,858 | -6.3% | 0.00% | – |
| Q4 2021 | $2,038,000 | -5.5% | 339,081 | +4.7% | 0.00% | – |
| Q3 2021 | $2,156,000 | +2.0% | 323,706 | +1.8% | 0.00% | – |
| Q2 2021 | $2,114,000 | +390.5% | 317,845 | +582.1% | 0.00% | – |
| Q1 2021 | $431,000 | -46.2% | 46,597 | +4.7% | 0.00% | – |
| Q4 2020 | $801,000 | +127.6% | 44,520 | +79.4% | 0.00% | – |
| Q3 2020 | $352,000 | +517.5% | 24,817 | +118.8% | 0.00% | – |
| Q2 2020 | $57,000 | – | 11,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 45,000 | $63 | 0.04% |
| FinDec Wealth Services, Inc. | 16,000 | $22,240 | 0.02% |
| DENVER WEALTH MANAGEMENT, INC. | 18,235 | $25,347 | 0.02% |
| Atom Investors LP | 18,298 | $25,434 | 0.01% |
| Laurion Capital Management LP | 722,100 | $1,003,719 | 0.01% |
| MAI Capital Management | 224,749 | $312,401 | 0.01% |
| Callan Capital, LLC | 31,147 | $43,294 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 25,975 | $36 | 0.00% |
| Tortoise Investment Management, LLC | 15,000 | $20,850 | 0.00% |
| America First Investment Advisors, LLC | 4,000 | $5,560 | 0.00% |